Dr. Todd E. Daynes, MD

Dr. Daynes practices at Daynes Eye and Lasik in Bountiful, Utah.

Dr. Daynes' NPI, 1053412494, was assigned on September 26, 2006. Dr. Daynes graduated from Spencer Fox Eccles School of Medicine in 2001. Dr. Daynes holds Utah license 5842999-1205.

Dr. Daynes' primary practice is Daynes Eye and Lasik, at 280 S Main St, Bountiful, UT 84010 in Davis County. The practice phone is (801) 263-2020.

Dr. Daynes' primary practice is Daynes Eye and Lasik in Bountiful, Utah. Dmand AI also links Dr. Daynes to 1 physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Daynes practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Daynes' primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Daynes is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Daynes is licensed in Utah.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Daynes treats.

CMS data shows 1,504 Medicare services from Dr. Daynes across 11 procedure codes in 2024, for 521 Medicare patients. Medicare paid $104,332 for them.

CMS counts 521 Medicare patients who saw Dr. Daynes in 2024. The largest group is 65 to 74, with 243 patients. 71% of them have high blood pressure, and 70% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Daynes' median patient age at 68, with 56% women.

In 2024, Dr. Daynes wrote 1,428 Medicare Part D claims for 403 patients. 65% of them were for generic drugs. CMS names the drug for 1,313 of them, across 15 drugs with 11 or more claims each, at $553,329 in total drug cost. In 2023, CMS named 1,483 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Daynes for performance year 2024, reported as part of a group. Dr. Daynes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 161 procedures of cataract surgery by Dr. Daynes, more than 81% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Daynes. The most frequent topics are Acrylic Resins, Cataract and Lens Capsule, Crystalline. Dr. Daynes' most frequent co-authors are Kim T. Doan, MD, Stacy R. Smith, MD and Terrence S. Spencer, MD.

CMS Open Payments shows 118 general payments to Dr. Daynes from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Shire North American Group Inc paid the most, $509.

Dmand AI lists 3 awards for Dr. Daynes, most recently CMS Stage 1 EHR in 2012.

Dr. Daynes graduated from Spencer Fox Eccles School of Medicine in 2001. Dr. Daynes is a member of AAO.

Dr. Daynes is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. HMO plans come from the most carriers, 14. Check the plan with the practice before a visit.